Cleerly’s momentum continues as AI specialists raise $106M
Cleerly, the Denver-based healthcare technology company focused on evaluating cardiovascular imaging findings with artificial intelligence (AI), has raised $106 million in Series C funding. Insight Partners led the round, with Battery Ventures and a list of previous investors also participating.
Cleerly plans to use the new funds to scale its commercial growth and generate more clinical evidence highlighting the effectiveness of its U.S. Food and Drug Administration (FDA)-approved, AI-enabled software offerings.
The announcement comes at the end of a busy year for Cleerly. The company received a new Category 1 CPT code for its coronary analysis evaluations from the American Medical Association, for example, and then received expanded Medicare coverage for that same software through multiple new local coverage determinations.
An example of Cleerly’s CAD Staging System, which uses AI to automatically assess the stenosis severity on coronary CT scans.
“This funding will allow us to expand our commercial reach, which is especially germane following our recent achievements in attaining Medicare coverage and a CPT Category I code for advanced plaque analysis,” James K. Min, MD, founder and CEO of Cleerly, said in a prepared statement. “We are very excited to see our purpose-driven mission come to life, making advanced cardiac care accessible to more patients and working towards our goal of eliminating heart attacks.”
“We are excited to support Cleerly in its mission to revolutionize cardiac care,” added Scott Barclay, managing director at Insight Partners. “Cleerly’s pioneering approach to advanced cardiovascular imaging, powered by AI-driven analysis, is elevating the field of diagnostic tools for coronary artery disease. With this investment, we look forward to helping Cleerly expand its reach and impact, bringing this potentially life-saving innovation to more patients and health systems nationally. We’re proud to be a part of Cleerly’s journey.”
Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.